Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9452222 Nucleic acids encoding modified relaxin polypeptides

Patent 9452222 was granted and assigned to Ambrx on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ambrx

Current Assignee

Ambrx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94522220

Patent Inventor Names

Nick Knudsen0

Ahma Hewet0

Jason Pinkstaff0

Kristine De Dios0

Lorraine Sullivan0

Vadim Kraynov0

Date of Patent

September 27, 2016

Patent Application Number

141523020

Date Filed

January 10, 2014

Patent Citations Received

‌

US Patent 12103955 Polynucleotides encoding relaxin

‌

US Patent 11786578 Modified relaxin polypeptides and their uses

Patent Primary Examiner

‌

Christine J. Saoud

Patent abstract

Modified relaxin polypeptides and their uses thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9452222 Nucleic acids encoding modified relaxin polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API